Sonoma Biotherapeutics

Drug Discovery

Sonoma Biotherapeutics is a private drug discovery company. It has raised $265 million across 1 recorded round; the latest was a $265 million Series B in Aug 2021.

PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$265.0M
Last round
Early Stage VC (Series B)
Aug 2021
How much has Sonoma Biotherapeutics raised?
$265.0Macross 1 recorded rounds · Aug 2021 – Aug 2021

Most recently, Sonoma Biotherapeutics raised $265.0M in its Early Stage VC (Series B) (Aug 2021).

Free account
More of Sonoma Biotherapeutics with a free account
  • ·Watch Sonoma Biotherapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Sonoma Biotherapeutics round by round

1 rounds
Aug 2021Early Stage VC (Series B)$265.0M▮
+ 1 more investors · free account

How much has Sonoma Biotherapeutics raised?

Sonoma Biotherapeutics has raised $265 million across 1 recorded round since 2021. The largest was a $265 million Series B in Aug 2021.

Sonoma Biotherapeutics has filed 1 Form D with the SEC, most recently in Aug 2021 ($265 million sold to 40 investors).

Frequently asked about Sonoma Biotherapeutics

How much has Sonoma Biotherapeutics raised?
Sonoma Biotherapeutics has raised $265.0M in total across 1 recorded funding rounds.
When was Sonoma Biotherapeutics's last funding round?
Sonoma Biotherapeutics's most recent recorded round was Early Stage VC (Series B) in Aug 2021, raising $265.0M.